Warren Buffett fit · Wonderful businesses at fair prices
Is Indivior Pharmaceuticals Inc (INDV) a Warren Buffett Stock?
Low Buffett fit - meets only 4/9 criteria; valuation, moat, or financial health flags risk.
35/100
DNot a fit
4/9 criteria passed
+8 sector-quality lift. Top-quintile within its sector on 4 of 5 quality metrics. Raw pillar score 27 → lifted to 35 before grade derivation.
Warren Buffett's Criteria, Applied to INDV
ROIC ≥ 15%
key85.7%
Gross margin ≥ 40%
key83.1%
Owner earnings yield ≥ 5%
key-2.0%
5y profitable
keyNo
Net Debt / EBITDA ≤ 3
0.7x
Revenue CAGR ≥ 8%
11.9%
EPS CAGR ≥ 8%
5.0%
FCF / Net income ≥ 0.8
-0.4x
Debt / Equity ≤ 1
-
How INDV Scores on Other Strategies
Live Financial Snapshot
Market cap
$4.26B
P/E (TTM)
19.0x
ROIC (TTM)
85.68%
Gross margin
83.11%
Other Warren Buffett fit reports
Frequently Asked Questions
What is INDV's Warren Buffett fit score?
INDV scores 35/100 on our Warren Buffett fit engine - grade D. Low Buffett fit - meets only 4/9 criteria; valuation, moat, or financial health flags risk.
Does Warren Buffett actually own INDV?
Our score is computed from financial fundamentals against Warren Buffett's published criteria. We don't claim that Warren Buffett personally owns or recommends INDV.
How often is this score updated?
INDV's Warren Buffett fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Key terms in this analysis
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Warren Buffett personally owns or recommends INDV.